Search Results - "Rassam, Saad"

Eradication of Minimal Residual Disease in B-Cell Chronic Lymphocytic Leukemia After Alemtuzumab Therapy Is Associated With Prolonged Survival by MORETON, Paul, KENNEDY, Ben, HILLMEN, Peter, LUCAS, Guy, LEACH, Michael, RASSAM, Saad M. B, HAYNES, Andrew, TIGHE, Jane, OSCIER, David, FEGAN, Christopher, RAWSTRON, Andy

“…To test whether eradication of minimal residual disease (MRD) in B-cell chronic lymphocytic leukemia (CLL) by alemtuzumab is associated with a prolongation of…”
Get full text

Guidelines on the diagnosis and management of Waldenström macroglobulinaemia by Owen, Roger G., Pratt, Guy, Auer, Rebecca L., Flatley, Rita, Kyriakou, Charalampia, Lunn, Michael P., Matthey, Francis, McCarthy, Helen, McNicholl, Feargal P., Rassam, Saad M., Wagner, Simon D., Streetly, Matthew, D'Sa, Shirley

Get full text

Parents providing palliative care for children with cancer by Rassam, Rima Saad, Huijer, Huda Abu-Saad, Noureddine, Samar, Smith, Ellen M Lavoie, Wolfe, Joanne, Fares, Souha, Abboud, Miguel R

“…Parents of children with cancer provide paediatric palliative care (PPC). However, the activities they perform remain underexplored, especially in low- and…”
Get full text

Drug cross‐resistance and therapy‐induced resistance in chronic lymphocytic leukaemia by an enhanced method of individualised tumour response testing by Bosanquet, Andrew G., Richards, Sue M., Wade, Rachel, Else, Monica, Matutes, Estella, Dyer, Martin J. S., Rassam, Saad M. B., Durant, Justin, Scadding, Sheila M., Raper, Steve L., Dearden, Claire E., Catovsky, Daniel

“…Summary Previous results with individualised tumour response testing (ITRT) in vitro in chronic lymphocytic leukaemia (CLL) have consistently shown good…”
Get full text

High remission rate in T-cell prolymphocytic leukemia with CAMPATH-1H by Dearden, Claire E., Matutes, Estella, Cazin, Bruno, Tjønnfjord, Geir E., Parreira, Antonio, Nomdedeu, Benet, Leoni, Pietro, Clark, Fiona J., Radia, Deepti, Rassam, Saad M.B., Roques, Tony, Ketterer, Nicolas, Brito-Babapulle, Vasantha, Dyer, Martin J.S., Catovsky, Daniel

“…T-cell prolymphocytic leukemia (T-PLL) is a chemotherapy-resistant malignancy with a median survival of 7.5 months. Preliminary results indicated a high…”
Get full text

Celebrating oncology nursing: from adversity to opportunity. The Global Power of Oncology Nursing Conference held virtually on the 15th November 2022 by Downing, Julia, Bağçivan, Gülcan, Burns, Kathryn, Challinor, Julia, Cruickshank, Susanne, de Villiers, Martje, de Los Rios de la Serna, Celia Diez, Doumit, Myrna, Kumaralingam, Nellie, Lodge, Mark, Mendoza, Lucia Robles, Rassam, Rima Saad, Samba, Vera, Tomlins, Elaine, Young, Annie

“…The Global Power of Oncology Nursing held their 3rd annual conference on 'Celebrating Oncology Nursing: From Adversity to Opportunity'. The conference, held…”
Get full text

Unfolding parental knowledge, attitudes, and beliefs toward palliative care for children with cancer by Rassam, Rima Saad, Huijer, Huda Abu‐Saad, Noureddine, Samar, Smith, Ellen M. Lavoie, Wolfe, Joanne, Fares, Souha, Abboud, Miguel R.

“…Background Parents’ views toward pediatric palliative care (PPC) remain underexplored, especially in low/middle‐income countries where care relies heavily on…”
Get full text

Bone Marrow Assessment in Asymptomatic IgM Monoclonal Gammopathies – Reply to Varettoni et al by Owen, Roger G., Pratt, Guy, Auer, Rebecca L., Flatley, Rita, Kyriakou, Charalampia, Lunn, Michael P., Matthey, Francis, McCarthy, Helen, McNicholl, Feargal P., Rassam, Saad M., Wagner, Simon D., Streetly, Matthew, D'Sa, Shirley

Get full text

High incidence of therapy‐related myelodysplasia and acute leukaemia in general haematology clinic patients treated with fludarabine and cyclophosphamide for indolent lymphoproliferative disorders by Bowcock, Stella J., Rassam, Saad M. B., Lim, Ziyi, Ward, Susan M., Ryali, Madan M., Mufti, Ghulam J.

Get full text

Florid Erythroid Dysplasia Mimicking Congenital Dyserythropoietic Anemia During the Preleukemic Phase of Acute Erythroleukemia by Anoop, Parameswaran, Lancaster, Donna L., Rassam, Saad M. B., Atra, Ayad

Get full text

Spontaneous remission of low‐grade B‐cell non‐Hodgkin's lymphoma following withdrawal of methotrexate in a patient with rheumatoid arthritis: case report and review of the literature by Baird, Richard D., Nellis van Zyl‐Smit, Richard, Dilke, Timothy, Scott, Sara E., Rassam, Saad M. B.

“…A 69‐year‐old woman, who had suffered from deforming rheumatoid arthritis since the age of 40 years, had been treated with methotrexate for 3 years. She…”
Get full text

Chemotherapy for cancer patients who present late by Bowcock, Stella J, Shee, Charles D, Rassam, Saad M B, Harper, Peter G

“…Credit: ULRIKE PREUSS/BMJ Data on patients with extremely poor performance status or who are moribund are surprisingly scanty, and chemotherapy trials often…”
Get full text

Thromboembolism in patients on thalidomide for myeloma by Bowcock, Stella J, Rassam, Saad M B, Ward, Sue M, Turner, Jacky T, Laffan, Mike

“…Seven cases of thromboembolism were found amongst 23 patients treated with thalidomide for myeloma over a total of 141.5 patient treatment months. Five…”
Get more information

Thalidomide is Highly Effective in a Patient with Meningeal Acute Myeloid Leukaemia by Baird, Richard, van Zyl-Smit, Richard Nellis, Iveson, Anne, Duddy, James, Rassam, Saad MB

“…We report a case of secondary acute myeloid leukaemia (AML) following high dose therapy for diffuse large B-cell non-Hodgkin's lymphoma (NHL) who developed…”
Get full text

British Society for Rheumatology guideline on management of adult and juvenile onset Sjögren disease by Price, Elizabeth J, Benjamin, Stuart, Bombardieri, Michele, Bowman, Simon, Carty, Sara, Ciurtin, Coziana, Crampton, Bridget, Dawson, Annabel, Fisher, Benjamin A, Giles, Ian, Glennon, Peter, Gupta, Monica, Hackett, Katie L, Larkin, Genevieve, Ng, Wan-Fai, Ramanan, Athimalaipet V, Rassam, Saad, Rauz, Saaeha, Smith, Guy, Sutcliffe, Nurhan, Tappuni, Anwar, Walsh, Stephen B

“…Sjögren disease (SD) is a chronic, autoimmune disease of unknown aetiology with significant impact on quality of life. Although dryness (sicca) of the eyes and…”
Get full text

Executive summary: British Society for Rheumatology guideline on management of adult and juvenile onset Sjögren disease by Price, Elizabeth J, Benjamin, Stuart, Bombardieri, Michele, Bowman, Simon, Carty, Sara, Ciurtin, Coziana, Crampton, Bridget, Dawson, Annabel, Fisher, Benjamin A, Giles, Ian, Glennon, Peter, Gupta, Monica, Hackett, Katie L, Larkin, Genevieve, Ng, Wan-Fai, Ramanan, Athimalaipet V, Rassam, Saad, Rauz, Saaeha, Smith, Guy, Sutcliffe, Nurhan, Tappuni, Anwar, Walsh, Stephen B

Get full text

The management of Sjögren’s syndrome: British Society for Rheumatology guideline scope by Price, Elizabeth, Allen, Alexander, Rauz, Saaeha, Tappuni, Anwar, Sutcliffe, Nurhan, Bombardieri, Michele, Carty, Sara, Ciurtin, Coziana, Crampton, Bridget, Duncalfe, Lisa, Fisher, Benjamin, Glennon, Peter, Hackett, Katie L, Larkin, Genevieve, Ng, Wan-Fai, Ramanan, Athimalaipet V, Rassam, Saad, Walsh, Stephen B, Bowman, Simon

“…Abstract The guideline will be developed using the methods and processes outlined in Creating Clinical Guidelines: Our Protocol [1]. This development process…”
Get full text

Novel Findings for the Role of Microenvironment and Heat Shock Proteins (HSP) in B -Cell Recptor (BCR) Activation, Disease Progression and Transformation of Follicular Non-Hodgkin Lymphoma (FL): Gene Expression Profiling (GEP) and Immuno-Histochemical (IH) Studies Reveal New Pathways for Potential Targeted Therapies by Rassam, Saad M B, Schofield, John, Malik, Farooq, Mohamedali, Azim M, Przychodzen, Bartlomiej, Elstein, Gabrielle, Mufti, Ghulam J

“…Introduction: Tumour infiltrating lymphocytes (TIL), tissue macrophages/monocytes (TMM) and follicular dendritic cells (FDC) have an important role in the…”
Get full text

T-Cell Profiling Shows Marked Differences in Gene Expression Between Tumour Infiltrating (TIL) and Peripheral Blood (PB) Antibody-Bead Selected T-Cells From Fresh Lymph Node and PB Samples in Follicular Non-Hodgkin's Lymphoma (FL): Possible implications for Immunomodulatory Therapy by Rassam, Saad M B, Malik, Farooq, Schofield, John, Ali, Haytham, Mufti, Ghulam J.

“…Abstract 683 FL is one of the commonest B-cell lymphomas accounting for 25–30% of all newcases of non-Hodgkin’s lymphoma. Median survival ranges from 6–10…”
Get full text

Breast cancer risk following Hodgkin lymphoma radiotherapy in relation to menstrual and reproductive factors by Cooke, R, Jones, M E, Cunningham, D, Falk, S J, Gilson, D, Hancock, B W, Harris, S J, Horwich, A, Hoskin, P J, Illidge, T, Linch, D C, Lister, T A, Lucraft, H H, Radford, J A, Stevens, A M, Syndikus, I, Williams, M V, Swerdlow, A J

“…Background: Women treated with supradiaphragmatic radiotherapy (sRT) for Hodgkin lymphoma (HL) at young ages have a substantially increased breast cancer risk…”
Get full text